UrgentRx partners with Denver-area sports franchises to be ‘Official Sponsor of Game Day Relief’
DENVER — UrgentRx on Tuesday teamed up with the NFL’s Denver Broncos, the NBA’s Indiana Pacers and Kroenke Sports & Entertainment — parent of NBA’s Denver Nuggets, NHL’s Colorado Avalanche and NLL’s Colorado Mammoth — to be the “Official Sponsor of Game Day Relief.”
“Headaches, upset stomach, allergies and other common ailments often strike when you’re away from your medicine cabinet — including when you just want to enjoy the game,” said Jordan Eisenberg, president UrgentRx. “Our partnerships with these great professional sports organizations puts UrgentRx Fast Powders within reach of sports fans, so they don’t have to worry about missing that crucial shot or the game-winning goal.”
As the “Official Sponsor of Game Day Relief,” UrgentRx is delivering its over-the-counter powdered medications via various game-day promotions and in-stadium sales at Pepsi Center, Mile High Stadium and Bankers Life Fieldhouse from stadium bathroom take-overs to “lucky row” game-day relief giveaways.
CHPA: More consumers more aware of APAP overdose concerns
WASHINGTON — New research released Tuesday found that when it comes to treating pain, a growing number of consumers know how to safely use medicines with acetaminophen and to avoid accidental overdose and liver damage. A nationwide consumer survey conducted by the Consumer Healthcare Products Association Educational Foundation, in conjunction with its work on the Acetaminophen Awareness Coalition’s Know Your Dose educational campaign, shows that consumer safe use knowledge and risk awareness has increased over a three year period (2010-2013).
“More than 50 million people use medicines containing acetaminophen each week to relieve pain. We are very encouraged to see more consumers today know how and why to follow the label and dosing directions when taking acetaminophen to ensure safe and appropriate use,” stated Emily Skor, executive director of the CHPA Educational Foundation. “These research findings validate the importance of our ongoing consumer education initiatives. They will continue to serve as a benchmark for educational efforts as we find new ways to engage and educate consumers about the safe use of medicines.”
“Awareness is a critical step toward behavior change. These strides in consumer knowledge about the safe use of pain relievers and acetaminophen specifically are gratifying, and reinforce the need for continued education to ensure that knowledge translates into a reduction in acetaminophen-related liver damage,” added Anne Norman, a family nurse practitioner and associate VP of education at the American Association of Nurse Practitioners. “In my own practice, I’ve seen patients unknowingly take more than one medicine containing acetaminophen at the same time and exceed the recommended daily dose. That’s why ongoing education is so important — via healthcare providers, via pharmacists, via media and other channels. Reaching consumers at key points of relevancy and impact remain important as we continue to work together to drive safe medicine use.”
Acetaminophen is found in more than 600 prescription and over-the-counter pain relievers, fever reducers and sleep aids as well as cough, cold, and allergy medicines. Acetaminophen is safe and effective when used as directed but there is a limit to how much can be taken in one day. The U.S. Food and Drug Administration recommends taking no more than 4,000 mg of acetaminophen in a 24-hour period. Taking more than directed is an overdose and can lead to liver damage.
Findings from the national survey of 1,000 consumers who have taken a pain reliever in the past 6-12 months show enhanced consumer knowledge and awareness of key medicine safety issues:
- Label reading: More consumers agree that it is “important to check the label to find out the maximum daily dose” of medicines (increased to 98% in 2013 from 93% in 2010);
- Following dosing instructions: More consumers agree it is “important not to exceed the dosing directions on the label” of pain relievers (increased to 96% in 2013 from 90% in 2010);
- Awareness of risk: More consumers understand that “exceeding the recommended daily dose of acetaminophen may lead to liver damage” (increased to 87% in 2013 from 78% in 2010); and
- Avoidance of “doubling up:” Knowledge that “acetaminophen can be found in many over-the-counter and prescription pain medicines” (increased to 87% from 80% in 2010) andu nderstanding that “it is possible to exceed the maximum daily dose when taking an OTC acetaminophen product at the same time as a prescription pain medicine” (increased to 81% from 76% in 2010).
USPSTF: Not enough evidence on taking supplements to prevent cardiovascular disease or cancer
WASHINGTON — The U.S. Preventive Services Task Force on Tuesday posted its final recommendation statement on vitamin, mineral and multivitamin supplements for the prevention of cardiovascular disease and cancer. However, the Task Force concluded there is not enough evidence to determine the effectiveness of taking vitamins and minerals to prevent cardiovascular disease or cancer.
Many people take vitamins and mineral supplements to improve or maintain overall health. However, this recommendation is limited to use of these vitamins and supplements specifically for the prevention of cardiovascular disease and cancer, USPSTF noted.
“Cardiovascular disease and cancer have a significant health impact in America, and we all want to find ways to prevent these diseases,” stated Task Force chair Virginia Moyer. “However, we found that there is not enough evidence to determine whether taking single or paired nutrients or a multivitamin helps to prevent cardiovascular disease or cancer.”
Additionally, there are two vitamins that the Task Force recommends against using: beta-carotene and vitamin E. “The evidence shows that there is no benefit to taking vitamin E and that beta-carotene can be harmful because it increases the risk of lung cancer in people who are already at increased risk for the disease,” commented Task Force co-chair Michael LeFevre. “Due to the uncertain benefit of vitamin supplements to prevent cardiovascular disease and cancer, health care professionals should use their best judgment and consider their patient’s health history, values, and preferences when having conversations about nutritional supplements.”
"The report’s conclusion that there is ‘…not enough evidence…’ for recommendations in the areas of cancer and cardiovascular disease should not be considered as a lack of benefit as there is a big difference between lack of research and lack of positive results," cautioned Duffy MacKay, SVP scientific and regulatory affairs for the Council for Responsible Nutrition. "Even with a current gap in the research, what few studies there were that met the USPSTF criteria pointed to a potential promise for cancer protection," he noted. "We strongly support both the need for more research and the need for the scientific community to come to terms with a rigorous approach to studying nutrition that may not reflect the current model of studying drugs."